Mary Ann Sayon
Gerontology · Hemet, CANPI 1164028080
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,399 of the $8,545 with a category attached, or 86.6%. It is spread thinly across 31 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 346 payments — averaging $24.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- AbbVie$925
- Corcept Therapeutics$854
- Amgen$794
- AstraZeneca$672
- Johnson & Johnson$529
- plus $3K from 25 others
What the payments were for
- Consulting fees$8009%
- Travel & lodging$3214%
- Food & beverage$7,39987%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $1,591 |
| AbbVie | 40 | $925 |
| Corcept Therapeutics | 64 | $854 |
| Amgen | 41 | $794 |
| AstraZeneca | 24 | $672 |
| Johnson & Johnson | 15 | $529 |
| Recordati_rare_diseases_inc. | 20 | $489 |
| Xeris Pharmaceuticals, Inc. | 24 | $442 |
| Bayer | 22 | $307 |
| Boehringer Ingelheim | 11 | $282 |
| Novo Nordisk | 10 | $245 |
| Merck | 8 | $168 |
| Abbott | 2 | $166 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $139 |
| Lundbeck LLC | 7 | $135 |
| Novartis | 7 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Amarin Pharma, Inc. | 3 | $71 |
| Viiv Healthcare Company | 1 | $70 |
| Biohaven Pharmaceuticals, Inc. | 1 | $69 |
| Pfizer | 4 | $62 |
| GSK | 4 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| Lilly USA, LLC | 2 | $54 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Hologic Sales And Service, LLC | 1 | $30 |
| Exact Sciences | 2 | $28 |
| Gilead | 1 | $25 |
| Shield Therapeutics Inc | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,545 in reported general payments places this provider in the 95th percentile of 348 gerontology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 34 | $657,250 |
| JardianceEmpagliflozin | 60 | $88,566 |
| IsturisaOsilodrostat Phosphate | 14 | $67,795 |
| EntrestoSacubitril/Valsartan | 51 | $57,219 |
| XareltoRivaroxaban | 40 | $39,002 |
| OzempicSemaglutide | 43 | $38,895 |
| FarxigaDapagliflozin Propanediol | 39 | $35,929 |
| VraylarCariprazine Hcl | 18 | $34,542 |
| KerendiaFinerenone | 38 | $32,104 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $27,194 |
| TrulicityDulaglutide | 23 | $26,220 |
| Nurtec OdtRimegepant Sulfate | 18 | $19,095 |
| Repatha SureclickEvolocumab | 14 | $18,786 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $16,023 |
| RexultiBrexpiprazole | 11 | $15,586 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Corcept TherapeuticsKorlym | $854 | $657,25034 claims |
| Boehringer IngelheimJardiance | $282 | $88,56660 claims |
| Recordati_rare_diseases_inc.Isturisa | $489 | $67,79514 claims |
| NovartisEntresto | $106 | $57,21951 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $672 | $51,95266 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $54 | $41,49436 claims |
| Johnson & JohnsonXarelto | $529 | $39,00240 claims |
| Novo NordiskOzempic | $245 | $38,89543 claims |
| AbbVieVraylar | $925 | $34,54218 claims |
| BayerKerendia | $307 | $32,10438 claims |
| GSKTrelegy Ellipta | $62 | $27,19444 claims |
| PfizerNurtec Odt | $62 | $19,09518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 348 gerontology providers in California.
Other gerontology in Hemet
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.